Home›Companies›Biotech & Pharma›Luminopia

Luminopia, Inc.

Updated Oct 27, 2026·Latest SEC filing Jun 29, 2023·Suggest an edit

About Luminopia

Luminopia is a private company based in Cambridge, Massachusetts. It has reported $36,532,482 raised in seven offerings on Form D since July 2016. Its chief executive is Scott Xiao.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 16, 2023Jun 29, 2023$15,811,759of $16.8M target10$1.5MEquityRule 506(b)Form D ↗
Oct 5, 2022Oct 19, 2022$4,074,997of $5.1M target15$271KEquityRule 506(b)Form D ↗
Nov 29, 2019Dec 13, 2019$11,110,726of $13.6M target29$383KEquity, Series Seed 1 Preferred Stock, Series Seed 2 Preferred Stock, Series Seed 3 Preferred Stock, Series Seed 4 Preferred Stock, & Series Seed 5 Preferred StockRule 506(b)Form D ↗
Sep 13, 2017Sep 27, 2017$1,250,000of $2.0M target3$416KEquity, Debt, Options, Securities on exercise, Convertible Promissory Notes, which may be converted into shares of an equity security of the Issuer.Rule 506(b)Form D ↗
Jun 5, 2017Sep 27, 2017$3,625,000of $5.1M target8$453KEquity, Debt, Options, Securities on exercise, Convertible Promissory Notes, which may be converted into shares of an equity security of the Issuer.Rule 506(b)Form D ↗
Oct 3, 2016Dec 14, 2016$410,000of $700K target8$51,250Equity, Debt, Options, Securities on exercise, CONVERTIBLE PROMISSORY NOTES WHICH MAY BE CONVERTED INTO SHARES OF PREFERRED STOCK.Rule 506(b)Form D ↗
Jul 5, 2016Jul 15, 2016$250,000of $500K target7$35,714Equity, Debt, Options, Securities on exercise, CONVERTIBLE PROMISSORY NOTES WHICH MAY BE CONVERTED INTO SHARES OF PREFERRED STOCK.Rule 506(b)Form D ↗
Total, seven offerings$36,532,482

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Luminopia's Form D filed Jun 29, 2023.

SX
Scott Xiao
Chief Executive Officer and director
CT
Casey Tansey
Director
RL
DT
Dean Travers
Director
WD
William Dai
Director
MJ

Earlier filings also listed Michelle Lee (director, last listed Oct 2022), Jeffrey Dunn (director, last listed Oct 2022), Joi Ito (director, last listed Dec 2019), Mark Dockser (executive officer, last listed Sep 2017) and Alexander Wendland (executive officer and director, last listed Sep 2017).

Sources

  1. SECLUMINOPIA, INC. filing history